May 9, 2018 – HighLife appoints Dr. Martin Rothman as independent member of the board
HighLife SAS, a medtech company focused on the development of a unique trans- catheter mitral valve replacement (TMVR) system to treat patients suffering from mitral regurgitation, announced today the appointment …